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Background: Circulating markers of inflammation in chronic obstructive pulmonary disease 
(COPD) may correlate to disease progression and extrapulmonary complications such as 
  malnourishment. However, surprisingly little is known about gender-related differences for 
circulating inflammatory markers in COPD.
Purpose: To characterize differences in circulating markers of inflammation in malnourished 
female and male patients with COPD.
Subjects: Thirty female and 11 male patients with a clinical diagnosis of COPD and malnour-
ishment were examined. A group of control subjects without evidence of COPD was recruited 
for comparison of some variables.
Methods: Blood samples were drawn, and the following parameters were studied: leukocytes 
and differential counts, C-reactive protein (CRP), tumor necrosis factor-α, interleukin (IL)-6 
and IL-8, myeloperoxidase (MPO), neutrophil elastase (NE), intracellular adhesion molecule-1, 
vascular endothelial adhesion molecule-1, and E-selectin.
Results: The mean neutrophil concentration was significantly (P = 0.019) higher in female 
(4.5 × 109/L) than in male patients with COPD (3.5 × 109/L) and significantly higher than in 
female control subjects (3.1 × 109/L) (P , 0.01, n = 85). The mean CRP values were consider-
ably higher in female (4.9 mg/mL) than in male patients with COPD (1.5 mg/mL), but the 
difference was not statistically significant (P = 0.20). The mean concentrations of IL-6 and IL-8 
tended to be higher in female than in male patients with COPD, but these differences did not 
reach statistical significance either (P . 0.05). Confounding factors (smoking, medication) 
could not explain the gender differences noted. The concentrations of MPO and NE displayed 
a strong correlation (r = 0.89; P , 0.01, n = 41) but revealed no gender differences. The latter 
was true for concentrations of adhesion molecules as well.
Conclusions: Our study puts forward evidence of a gender-related difference in systemic inflam-
mation in malnourished patients with COPD in terms of circulating neutrophils being more 
abundant in female patients. Among these female patients, there was also a trend toward an 
increase in two neutrophil-mobilizing cytokines. New and better-powered studies are warranted 
to confirm and characterize this potentially important phenomenon in greater detail.
Keywords: chronic obstructive pulmonary disease, inflammatory markers, leukocytosis, 
malnutrition
Introduction
Chronic obstructive pulmonary disease (COPD) is becoming an increasing clinical 
problem in women. The number of females dying from COPD in the US has outnum-
bered that in males since the year 2000.1 In 2006, for the first time, more female (1291) International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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than male (1274) patients died in Sweden from COPD, 
according to official death statistics.2 It seems feasible that 
increasing proportions of smokers among females in the 
generations born during the first half of the 20th century can 
account for the referred increasing death numbers in females. 
Whether females are also more susceptible to lung damage 
caused by cigarette smoke remains controversial; epidemio-
logical studies are contradictory.3,4
The occurrence of systemic inflammation in COPD 
patients with severe disease has been reported in several 
studies, and COPD is now regarded as a disease with systemic 
complications, including an increase in circulating markers 
of inflammation.5 Findings of leukocytosis dominated by 
neutrophils and elevated levels of C-reactive protein (CRP) 
are frequently reported in studies on COPD patients.6–8 
For example, a rapid decline in the forced expiratory volume 
in one second (FEV1) in dust-exposed smokers with increased 
concentrations of circulating neutrophils has been reported,9 
and in a group of predominantly male COPD patients, 
a correlation between CRP values and decline in FEV1 has 
been observed.10
Whether there is a difference in circulating markers of 
inflammation between female and male patients with COPD 
has been the subject of surprisingly few studies. There is one 
study reporting a stronger correlation between levels of 
circulating CRP and a decline in FEV1 in male than in female 
patients with COPD.11
In this study, we examined whether there is a gender-
related difference in circulating markers of systemic inflam-
mation in patients with COPD and malnourishment by 
comparing the concentrations of circulating leukocytes, 
proteases, cytokines, and adhesion molecules in female and 
male patients with COPD and malnourishment.
Methods
study subjects
Malnourished  COPD  patients  (body  mass  index 
[BMI] ,21 kg/m2 or involuntary weight loss of .10% during 
the last 3 months) were included consecutively from the 
outpatient clinic at the Department of Respiratory Medicine 
at Sahlgrenska University Hospital, Gothenburg, Sweden. 
All patients had a clinical diagnosis of COPD and met the 
following inclusion criteria: a smoking history of .10 
  pack-years, age over 45 years, a spirometry test performed 
during the last 12 months showing an FEV1/FVC ratio less 
than −2 standard deviations (SD) of predicted normal and 
FEV1 ,60% of predicted normal value. Every cigarette or 
other form of nicotine consumed and every dose of 
  medication taken during the 24-hour period before the visit 
was recorded by the patients. Blood samples were taken in 
the morning after fasting for 12 hours. This study material 
was previously used for studying factors of importance to 
basal metabolic rate in malnourished COPD patients.12
As a control group for leukocyte, differential counts, and 
CRP, a study population aged 65–81 years was randomly 
selected from national registration. Determination of lung 
function through spirometry was conducted, and subjects 
with an FEV1/FVC ,0.65 were excluded (1101 subjects were 
invited, of whom 193 chose to take part, and 41 were 
excluded due to an FEV1/FVC ,0.65 indicating COPD). 
Smoking habits were recorded.
Blood sampling and analysis of systemic 
inflammatory markers
A volume of 42 mL of blood was collected from each study 
subject. Serum was prepared for analysis of soluble inflam-
matory markers, and cell differential counts were performed 
as described below.
The concentration of CRP was measured utilizing a high 
sensitivity latex reagent kit (hs-CRP; Roche Diagnostics, 
Mannheim, Germany) using a modular polypeptide analyzer 
(Roche, Tokyo, Japan) at the accredited laboratory at the 
Department of Clinical Chemistry, Sahlgrenska University 
Hospital. The intra-assay coefficient of variation of the CRP 
method was 2% at 1 mg/L and 1% at 20 mg/L. The concentra-
tion of leukocytes was obtained from an automated blood 
differential count analysis at the same laboratory. Commer-
cially available enzyme-linked immunosorbent serologic 
assay (ELISA) kits were utilized to analyze the serum con-
centrations of tumor necrosis factor (TNF)-α (Catalog No. 
HSTA00D; R&D Systems, Abingdon, England) and 
interleukin (IL)-6 (Catalog No. HS600B; R&D Systems) and 
IL-8 (Catalog No. D800C; R&D Systems). The concentration 
of myeloperoxidase (MPO) in serum was also measured using 
ELISA (HK327; Hycult Biotechnologies, Uden, the 
Netherlands), in this case after diluting the serum 1:10. The 
concentration of neutrophil elastase (NE) (µg/L), was 
assessed using the latex bead concentration method as previ-
ously described.13,14 The adhesion molecules intracellular 
adhesion molecule (ICAM)-1, vascular endothelial adhesion 
molecule (VCAM)-1, and E-selectin were measured using 
ELISA (Diaclone, Besancon, France) as well.
ethics
The Committee for Medical Research Ethics at the University 
of Gothenburg approved the study (diary number S349–03). International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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The patients were informed of the nature and purpose of the 
study. Oral as well as written informed consent was obtained.
statistics
Parametric, descriptive statistics were used to describe the 
study population. Two-sided t-tests were used to compare 
groups. Clinical characteristics were used as independent 
predictors of neutrophil count in univariate regression 
  analysis. Variables that were associated with neutrophil count 
with a P , 0.15 were, in addition to gender, included in a 
multivariate linear forward regression analysis. All statistical 
analysis was performed using PASW Statistics 18.0.0   (SPSS 
Inc., Chicago, IL, USA).
Results
The clinical characteristics of the patients (11 males and 
30 females) are presented in Table 1. BMI and the amount 
of cigarettes smoked (pack-years) were significantly lower 
in female compared with male patients. No other statistically 
significant gender-related differences were observed with 
reference to the referred clinical characteristics. Slightly 
fewer female than male patients used β2-adrenoceptor 
agonists and inhaled steroids. Three patients, all female, used 
oral steroids. The clinical characteristics of the control group 
are presented in Table 2.
The serum concentrations of inflammatory cells and 
inflammatory markers in male and female patients are 
  presented in Table 3. The mean concentration of circulating 
neutrophils was significantly higher in female than in male 
patients (P = 0.019). The mean corresponding CRP 
concentration was also considerably higher in female 
than in male patients, but this difference did not reach 
statistical   significance. No other gender-related difference 
was observed with reference to clinical characteristics.
The concentration of circulating neutrophils in female 
COPD patients was clearly higher than in female control 
subjects (4.5 compared with 3.1 × 109/L, P , 0.01, n = 85). 
No corresponding difference was observed for male patients 
and control subjects (3.5 compared with 3.1 × 109/L, 
P = 0.29, n = 66). In addition, the concentration of circulating 
CRP was significantly higher in female patients compared 
with female control subjects (4.9 compared with 2.3 mg/mL, 
P = 0.023, n = 85). With regard to CRP in males, the con-
centration tended to be lower in patients with COPD than in 
healthy control subjects, but this difference did not reach 
statistical significance (1.5 compared with 3.9 mg/mL, 
P = 0.43, n = 66).
The variables that were associated with neutrophil 
concentrations with a P , 0.15 in univariate regression 
Table 1 Descriptives of COPD cases (mean [sD])
Males 
(n = 11)
Females 
(n = 30)
P
Age (years) 65 (9) 63 (9) 0.47
Body mass index (kg/m2) 19.8 (1.1) 18.5 (2.1) 0.045
FeV1 (percentage predicted) 36 (15) 40 (15) 0.48
PO2 9.8 (0.9) 9.2 (1.5) 0.27
PCO2 5.6 (0.6) 5.7 (0.6) 0.61
Pack-years 47 (13) 34 (10) ,0.01
Percentage of current smokers 36 37
Percentage of β2-adrenoceptor 
agonists users
82 60
Percentage of inhalation steroid users 91 77
Percentage of anticholinergic drug users 73 80
Abbreviations:  COPD,  chronic  obstructive  pulmonary  disease;  FeV1,  forced 
expiratory volume in one second; PO2, partial pressure of oxygen in arterial blood; 
PCO2, partial pressure of carbon dioxide in arterial blood; sD, standard deviation.
Table 2 Descriptives of the control group (mean [sD]) (n = 151)
Males 
(n = 66)
Females 
(n = 85)
P
Age (years) 72 (5) 72 (5) 0.43
Body mass index (kg/m2) 26.0 (3.0) 25.5 (3.8) 0.37
FeV1 (percentage predicted) 102 (15) 107 (17) 0.053
Percentage of current smokers 5 12 –
Abbreviations:  FeV1,  forced  expiratory  volume  in  one  second;  sD,  standard 
deviation.
Table 3 Inflammatory cells and inflammatory markers in serum 
of COPD patients (mean [sD])
Males 
(n = 11)
Females 
(n = 30)
Pa
Monocytes (×109/L) 0.65 (0.15) 0.63 (0.16) 
(n = 29)
0.75
Lymphocytes (×109/L) 2.3 (1.1) 2.3 (0.8) 
(n = 29)
0.89
neutrophils (×109/L) 3.5 (0.7) 4.5 (1.2) 
(n = 29)
0.019
CrP (mg/mL) 1.5 (1.5) 4.9 (8.6) 0.20
IL-6 (pg/mL) 3.6 (1.8) 3.9 (2.5) 0.75
TnF-α (pg/mL) 2.5 (2.5) 1.6 (1.4) 0.17
IL-8 (pg/mL) 15.1 (4.4) 17.7 (7.7) 0.30
MPO (ng/mL) 165 (114) 153 (116) 0.75
ne (ng/mL) 243 (201) 246 (235) 0.98
ICAM-1 (ng/mL) 683 (138) 734 (172) 0.38
VCAM-1 (ng/mL) 940 (202) 993 (264) 0.55
e-selectin (ng/mL) 75 (39) 66 (28) 
(n = 29)
0.39
Note: at-test.
Abbreviations:  COPD,  chronic  obstructive  pulmonary  disease;  CrP, 
C-reactive protein; ICAM, intracellular adhesion molecule; IL, interleukin; MPO, 
myeloperoxidase;  ne,  neutrophil  elastase;  sD,  standard  deviation;  TnF,  tumor 
necrosis factor; VCAM, vascular endothelial adhesion molecule.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
86
Larsson et al
analysis were NE, MPO, TNF-α, pack-years, and BMI. 
The result from the multivariate linear forward regression 
analysis is presented in Table 4. Only gender and MPO sig-
nificantly explained the variation in neutrophil concentration. 
NE, TNF-α, pack-years, and BMI did not increase the degree 
of explanation of the variation in neutrophil concentration. 
The neutrophil concentrations of the different subgroups are 
presented in Table 5. Notably, there were no significant differ-
ences between smokers and exsmokers, nicotine users and 
nonusers, or patients using or not using β2-adrenoceptor ago-
nists or inhaled steroids. The concentration of circulating 
neutrophils in users of anticholinergic drugs was considerably 
(but not statistically significantly) higher than in nonusers. 
Of the exsmoking nicotine users, two patients used nicotine 
patches, two patients used nicotine chewing gum, and 
five patients used snuff. There was no difference in neutrophil 
concentration between snuff users and nonsnuffers (a mean 
concentration of 4.2 × 109/L in both groups).
A scatter plot for MPO and NE concentrations is 
  presented in Figure 1, and the correlation for these two out-
comes was strong and statistically significant (r = 0.89; 
P , 0.01, n = 41).
We found no statistically significant differences for the 
female and male COPD patients with respect to concentra-
tions of adhesion molecules (Table 3).
Discussion
In this observational study, we found significantly higher 
concentrations of circulating neutrophils in female than in 
male COPD patients with malnourishment. We could not 
identify any confounding factor explaining this difference, 
taking smoking, use of nicotine, and medication into account. 
The only variable identified other than gender related to 
neutrophil concentrations in the forward regression model 
was the concentration of MPO in serum. This is not   surprising, 
because MPO might be produced by neutrophils.15 Users of 
inhaled steroids had marginally higher neutrophil concentra-
tions than nonsteroid users, in line with previous studies.16 
Notably, fewer female than male patients used inhaled steroids. 
Thus, the difference between users and nonusers of inhaled 
steroids cannot explain the gender difference in neutrophil 
concentrations in our study. Just like the use of inhaled ste-
roids, the use of oral steroids will increase neutrophil con-
centrations.17 The key results of our current study did not, 
however, change in any way if the three patients taking oral 
steroids were excluded. There were also other small gender 
differences concerning pharmacological therapy. Fewer 
females than males used β2-adrenoceptor agonists. On the 
other hand, more female patients used anticholinergic drugs 
compared with male patients. The reason for these differences 
and their possible effects on neutrophil concentrations remains 
unclear. The finding of a considerably, but not significantly, 
Table 4 results from the multivariate linear forward regression, 
r2 = 0.25
Variable B Standard error P-value
Intercept 2.8 0.4 ,0.001
gender 1.1 0.4 0.0061
MPO 0.0045 0.0019 0.021
Abbreviation: MPO, myeloperoxidase.
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Figure 1 relation between MPO and ne in serum (r = 0.89; P , 0.01, n = 41) in 
malnourished COPD patients. 
Abbreviaions: COPD, chronic obstructive pulmonary disease; MPO, myeloperoxi-
dase; ne, neutrophil elastase.
Table 5 number of neutrophils in different subgroups of the 
population (mean [sD])
Neutrophils 
(×109/L)
Pa
Males (n = 11) 
Females (n = 29)
3.5 (0.7) 
4.5 (1.2)
0.019
smokers (n = 15) 
exsmokers (n = 25)
4.3 (1.1) 
4.2 (1.3)
0.65
nicotinists (n = 24) 
non-nicotinists (n = 16)
4.2 (1.2) 
4.2 (1.2)
0.99
Users of β2-adrenoceptor agonists (n = 27) 
nonusers of β2-adrenoceptor agonists (n = 13)
4.1 (1.3) 
4.5 (0.8)
0.27
Users of inhalation steroids (n = 32) 
nonusers of inhalation steroids (n = 8)
4.3 (1.2) 
4.1 (1.1)
0.70
Users of anticholinergic drug (n = 32) 
nonusers of anticholinergic drug (n = 8)
4.4 (1.2) 
3.5 (1.0)
0.060
Note: at-test. 
Abbreviation: sD, standard deviation.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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higher concentration of circulation neutrophils in users of 
anticholinergic drugs compared with nonusers is somewhat 
surprising. Anticholinergic drugs are supposed to ameliorate 
neutrophilic inflammation.18
Our finding of significantly elevated neutrophil concen-
trations in female COPD patients must be interpreted with 
care, as this outcome was not the primary study variable of 
this investigation. However, in another, ongoing study of 
COPD patients (including patients with normal weight as 
well as malnourished patients) we found the same pattern 
(unpublished observations). The preliminary results of the 
referred, ongoing study thus support our current study.
Notably, we observed no clear difference in neutrophil 
concentrations for female and male control subjects. In line 
with this, clinically applied normal values for neutrophils do 
not differ for female and male subjects either. The comparison 
with the control group also indicates that the gender 
difference noted in the COPD patients is caused by increased 
neutrophil concentration in females rather then decreased 
concentrations in men.
We determined the concentrations of the neutrophil- 
mobilizing cytokines IL-6 and IL-8 to look for molecular 
correlates that could explain the increased neutrophil concen-
tration in the female COPD patients included in our current 
study. Whereas the concentrations of both these cytokines 
tended to be higher among female patients, the difference 
compared with male patients did not reach statistical 
  significance. Even though not conclusive, these findings are 
compatible with the archetype chemokine IL-8 and the 
neutrophil-activating cytokine IL-6, contributing to a gender 
difference in the concentration of circulating neutrophils, and 
it can be speculated that a better-powered study may prove 
this to be the case in the future.
Estrogens reduce the expression of adhesion molecules, 
leading to less extravasation of inflammatory cells.19 To study 
the hypothesis that the higher serum concentrations of 
neutrophils in female COPD patients were caused by low 
expression of adhesion molecules, which would reduce the 
capacity for extravascular migration, we studied ICAM-1, 
VCAM-1, and E-selectin. Hypothetically, a low expression 
of these molecules would lead to a larger fraction of neutro-
phils remaining in the circulation. However, we obtained no 
evidence supporting this hypothesis. On the contrary, the 
mean concentration of ICAM-1 and VCAM-1, respectively, 
was higher in female than in male patients, although not 
significantly so, suggesting more expression of these mole-
cules at the cellular level, if anything. Furthermore, there was 
no correlation between the concentrations of inflammatory 
cells and circulating adhesion molecules.
The concentrations of circulating MPO and NE were 
determined to assess whether the increased concentrations 
of circulating neutrophils in female COPD patients were 
associated with an increased release of neutrophil-derived 
proinflammatory compounds. No evidence for this was 
found, however. There were no clear differences in MPO 
and NE concentrations between female and male COPD 
patients. The concentrations of MPO and NE did, however, 
display a very strong correlation to one another. That finding 
is compatible with a shared source at the cellular level. 
However, this source may not be the circulating neutrophil, 
as no correlation was found between MPO or NE, on the one 
hand, and the neutrophil concentration, on the other hand. 
We speculate that neutrophils residing in the lung tissue could 
be one possible source.
The concentrations of circulating CRP were considerably 
higher in female than in male patients with COPD and 
significantly higher in female patients than in female control 
subjects. Although the gender difference in subjects with 
COPD was not statistically significant, this is of concern. 
This is because, in elderly subjects, slightly elevated concen-
trations of CRP are reported as predictors of frailty and 
osteoporosis.20 Elevated CRP concentrations are also corre-
lated to an increased risk of cardiovascular mortality.21 In the 
general elderly population in Sweden, there is no difference 
in CRP concentrations for female and male subjects.22
Conclusion
Data show that the concentration of circulating neutrophils 
is higher in female than in male COPD patients with 
malnourishment. This difference is not explained by differ-
ences in smoking habits, use of nicotine, or inhalation ste-
roids. The results are compatible with, but do not prove, the 
idea that concentrations of circulating IL-6 and IL-8 relate 
to the observed difference in neutrophils, and this clearly 
deserves to be evaluated in better-powered studies in the 
future. This type of gender difference in circulating markers 
of inflammation may prove important to understanding the 
link between disease progression and systemic complications 
in COPD and may lead to new therapeutic targets as well.
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